We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Michael R. Shanks
Michael R. Shanks
Products
PRODUCTS
Astellas Pharma Tech Co., Ltd.
Jacek Cieslak
,
Michael R. Shanks
, and
Maxwell Van Tassell
Price:
$117.00
View
Vetter Pharma-Fertigung GmbH & Co. KG
Ashley N. Queen
and
Michael R. Shanks
Price:
$117.00
View
Aspen SVP Pty Ltd.
Cheryl Clausen
and
Michael R. Shanks
Price:
$117.00
View
Aspen SVP Pty, Ltd.
Cheryl Clausen
and
Michael R. Shanks
Price:
$117.00
View
Samsung Biologics Corp., Ltd.
Virginia Carroll
,
Diane L. Raccasi
, and
Michael R. Shanks
Price:
$117.00
View
Sandoz GmbH
Laura Fontan
,
Deborah Schmiel
,
Michael R. Shanks
, and
Marjorie A. Shapiro
Price:
$117.00
View
Biogen (Denmark) Manufacturing ApS
Ralph M. Bernstein
,
Brian M. Janelsins
, and
Michael R. Shanks
Price:
$117.00
View
Amgen, Inc., Amgen Manufacturing, Ltd.
Christopher Downey
,
Michael R. Shanks
,
Jose Velez
, and
Timothy Wadkin
Price:
$117.00
View
GlaxoSmithKline
M Gutierrez Lugo
,
Richard A. Lyght
,
F Namuswe
,
Thuy T. Nguyen
,
Zhihao Peter Qiu
, and
Michael R. Shanks
Price:
$117.00
View
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
EUSA Pharma to Begin Phase 3 Trial of Siltuximab for COVID-19 in U.S.
FDA Issues Emergency Use Authorization for Centogene’s COVID-19 Assay
Regeneron Begins Phase 3 Trial of Antibody Cocktail for COVID-19
Becton Dickinson Earns EUA for Point-of-Care COVID-19 Test
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
